Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Rory M. Bade(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Waddah Arafat(Southwestern Medical Center), Matthew C. Mannino(University of Wisconsin–Madison), Hamid Emamekhoo(University of Wisconsin Carbone Cancer Center), Toni Choueri(Dana-Farber Cancer Institute), David J. Niles, Tamara S. Rodems(Therapeutics Clinical Research), Erika Héninger(University of Wisconsin Carbone Cancer Center), Xiao X. Wei(Dana-Farber Cancer Institute), John A. Steinharter(Memorial Sloan Kettering Cancer Center), E. Jason Abel(University of Wisconsin–Madison), Jamie M. Sperger(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Serena K. Wolfe(University of Wisconsin–Madison), Jennifer L. Schehr(University of Wisconsin–Madison), Charlotte N. Stahlfeld(University of Wisconsin–Madison), Benjamin K. Gibbs(University of Wisconsin Carbone Cancer Center), David J. Beebe(University of Wisconsin–Madison), Joshua A. Desotelle(University of Wisconsin–Madison), Anupama Singh(University of Wisconsin–Madison)
Cited by 24
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancerdiagnostic approach
|Nature|2020|1k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650